AIMS/HYPOTHESIS: The limited availability of deceased donor pancreases suitable for pancreas and islet transplantation calls for a broader utilisation of donor tissue for transplantation purposes. Young donors, representing, fortunately, a minor but significant pool of individuals, have been largely under-employed, mainly because of anatomical and functional incompatibilities with potential recipients. For islet transplantation, the isolation of pancreatic islets from young donors rarely occurs, because of technical problems. As a result of the peculiar characteristics of young donor pancreases, the standard isolation procedure does not allow efficient separation of the islets from the surrounding exocrine tissue, and favours the generation of mantled islets. Nonetheless, young donor islets offer high qualitative and clinically appealing characteristics. SUBJECTS AND METHODS: We standardised a modified methodology to obtain purified and mantle-free human islets from young donors. This method principally involves efficient delivery of isolation enzyme with reduced mechanical disruption of the pancreas combined with additional filtration steps. RESULTS: We were able to obtain purified and mantle-free human islets from donors as young as 6 months of age with good morphological and functional properties. The good qualitative characteristics of the islets, evidenced in vitro, were proven in vivo, as they were qualitatively superior to islets of older donors in transplantation studies. CONCLUSIONS/ INTERPRETATION: This study justifies the utilisation of islets derived from young donors for islet transplantation.
AIMS/HYPOTHESIS: The limited availability of deceased donor pancreases suitable for pancreas and islet transplantation calls for a broader utilisation of donor tissue for transplantation purposes. Young donors, representing, fortunately, a minor but significant pool of individuals, have been largely under-employed, mainly because of anatomical and functional incompatibilities with potential recipients. For islet transplantation, the isolation of pancreatic islets from young donors rarely occurs, because of technical problems. As a result of the peculiar characteristics of young donor pancreases, the standard isolation procedure does not allow efficient separation of the islets from the surrounding exocrine tissue, and favours the generation of mantled islets. Nonetheless, young donor islets offer high qualitative and clinically appealing characteristics. SUBJECTS AND METHODS: We standardised a modified methodology to obtain purified and mantle-free human islets from young donors. This method principally involves efficient delivery of isolation enzyme with reduced mechanical disruption of the pancreas combined with additional filtration steps. RESULTS: We were able to obtain purified and mantle-free human islets from donors as young as 6 months of age with good morphological and functional properties. The good qualitative characteristics of the islets, evidenced in vitro, were proven in vivo, as they were qualitatively superior to islets of older donors in transplantation studies. CONCLUSIONS/ INTERPRETATION: This study justifies the utilisation of islets derived from young donors for islet transplantation.
Authors: C Ricordi; R Alejandro; Y Zeng; A Tzakis; A Casavilla; R Jaffe; D H Mintz; T E Starzl Journal: Transplant Proc Date: 1991-02 Impact factor: 1.066
Authors: Olle Korsgren; B Nilsson; C Berne; M Felldin; A Foss; R Kallen; T Lundgren; K Salmela; A Tibell; G Tufveson Journal: Transplantation Date: 2005-05-27 Impact factor: 4.939
Authors: Srinath Chinnakotla; David M Radosevich; Ty B Dunn; Melena D Bellin; Martin L Freeman; Sarah J Schwarzenberg; A N Balamurugan; Josh Wilhelm; Barbara Bland; Selwyn M Vickers; Gregory J Beilman; David E R Sutherland; Timothy L Pruett Journal: J Am Coll Surg Date: 2014-01-10 Impact factor: 6.113
Authors: Thomas Delong; Timothy A Wiles; Rocky L Baker; Brenda Bradley; Gene Barbour; Richard Reisdorph; Michael Armstrong; Roger L Powell; Nichole Reisdorph; Nitesh Kumar; Colleen M Elso; Megan DeNicola; Rita Bottino; Alvin C Powers; David M Harlan; Sally C Kent; Stuart I Mannering; Kathryn Haskins Journal: Science Date: 2016-02-12 Impact factor: 47.728
Authors: Srinath Chinnakotla; Melena D Bellin; Sarah J Schwarzenberg; David M Radosevich; Marie Cook; Ty B Dunn; Gregory J Beilman; Martin L Freeman; A N Balamurugan; Josh Wilhelm; Barbara Bland; Jose M Jimenez-Vega; Bernhard J Hering; Selwyn M Vickers; Timothy L Pruett; David E R Sutherland Journal: Ann Surg Date: 2014-07 Impact factor: 12.969
Authors: Meirigeng Qi; Luis Valiente; Brian McFadden; Keiko Omori; Shiela Bilbao; Jemily Juan; Jeffrey Rawson; Stephen Scott; Kevin Ferreri; Yoko Mullen; Mohamed El-Shahawy; Donald Dafoe; Fouad Kandeel; Ismail H Al-Abdullah Journal: Transplant Direct Date: 2015-05
Authors: G V Rao; R Pradeep; M Sasikala; P Pavan Kumar; V V Krishna; G Mahesh Shetty; R Talukdar; M Tandan; R Jagadeesh; D Nageshwar Reddy Journal: Indian J Gastroenterol Date: 2018-10-01
Authors: Yue J Wang; Jonathan Schug; Kyoung-Jae Won; Chengyang Liu; Ali Naji; Dana Avrahami; Maria L Golson; Klaus H Kaestner Journal: Diabetes Date: 2016-06-30 Impact factor: 9.461
Authors: Srinath Chinnakotla; Gregory J Beilman; Ty B Dunn; Melena D Bellin; Martin L Freeman; David M Radosevich; Mustafa Arain; Stuart K Amateau; J Shawn Mallery; Sarah J Schwarzenberg; Alfred Clavel; Joshua Wilhelm; R Paul Robertson; Louise Berry; Marie Cook; Bernhard J Hering; David E R Sutherland; Timothy L Pruett Journal: Ann Surg Date: 2015-10 Impact factor: 12.969
Authors: Barbara M Schulte; Matthijs Kramer; Marleen Ansems; Kjerstin H W Lanke; Neeltje van Doremalen; Jon D Piganelli; Rita Bottino; Massimo Trucco; Jochem M D Galama; Gosse J Adema; Frank J M van Kuppeveld Journal: Diabetes Date: 2010-01-13 Impact factor: 9.461